BEAT

BEAT

USD

Heartbeam Inc. Common Stock

$1.915-0.045 (-2.276%)

实时价格

Healthcare
Health Information Services
美国

价格图表

关键指标

市场指标
公司基本面
交易统计

市场指标

开盘价

$1.960

最高价

$2.040

最低价

$1.823

成交量

0.00M

公司基本面

市值

64.6M

所属行业

Health Information Services

国家/地区

United States

交易统计

平均成交量

0.09M

交易所

NCM

货币

USD

52周价格范围

最低价 $1.45当前价 $1.915最高价 $3.48

AI分析报告

最后更新: 2025年4月24日
由AI生成数据来源: Yahoo Finance, Bloomberg, SEC

BEAT (Heartbeam Inc. Common Stock): Analyzing Recent Moves & What Might Come Next

Stock Symbol: BEAT Generate Date: 2025-04-24 18:24:16

Let's break down what's been happening with Heartbeam stock lately, looking at the latest news, how the price has been acting, and what some predictions are saying.

Recent News Buzz: A Positive Beat

Good news hit the wires today for Heartbeam. They announced they're teaming up with AccurKardia. Think of it as two companies known for their work in monitoring heart activity joining forces. Heartbeam focuses on the recording side (like those wearable ECG devices), and AccurKardia is strong on the analysis part.

What does this mean? Well, collaborations like this usually aim to make products better or reach more customers. For Heartbeam, it sounds like a move to improve their cardiac monitoring tech, specifically making it more innovative. This kind of news is generally seen as a positive step for a medical technology company, suggesting progress and potential for future products or services. It gives the stock a bit of a positive vibe today.

Price Check: A Recent Jump

Looking at the stock's journey over the past month or so, it's been a bit of a bumpy ride, mostly trending downwards from the low $2 range towards the mid-$1s. It hit a recent low around $1.45$ on April 7th. Volume, which is how many shares are trading hands, has generally been pretty low, often under 100,000 shares a day.

But then came today, April 24th. The price saw a noticeable jump, hitting a high of $1.85$ and opening significantly higher than the previous day's close. Importantly, the volume picked up quite a bit today compared to the quiet trading days just before it. This kind of price spike on increased volume often happens when positive news comes out.

Interestingly, an AI prediction model saw things differently for today, predicting a slight drop of 1.28%. Clearly, the news-driven price action today went against that specific prediction. However, the same AI model predicts small positive moves for the next couple of days (0.27% and 0.68%).

Putting It Together: Outlook & Ideas

So, you've got positive news about a collaboration that could boost Heartbeam's core business, and the stock price reacted strongly today with a noticeable jump and higher trading volume. This recent price action, especially today's move, seems to be the dominant signal right now, overriding the AI's prediction for today.

Based on the news and today's price spike, the apparent near-term leaning seems to favor potential buyers, suggesting the positive news has sparked some interest and could potentially lead to further upward movement or at least stabilize the recent downtrend.

Potential Entry Consideration: Given the spike today, jumping in immediately might mean buying after a quick run-up. If someone were considering this stock based on the news, one possible strategy might be to watch if the price consolidates or pulls back slightly after this initial reaction. The recommendation data mentioned potential entry points around $1.56 - $1.59$ previously, but the price is now above that. A potential level to watch after the spike could be a retest of today's opening price or the previous day's close, if it pulls back.

Potential Exit/Stop-Loss Consideration: Managing risk is always key. The recommendation data suggested a stop-loss around $1.43$. Given the recent price action, a tighter stop-loss could be considered below the low of today's spike ($1.61$) or perhaps below the recent low from April 21st ($1.50$). For taking profits, the recommendation's target of $1.62$ has already been passed. You'd likely look at previous price levels where the stock faced resistance, perhaps around the $2.00$ mark or higher, or simply trail a stop-loss to protect gains if the positive momentum continues.

Company Context

Remember, Heartbeam is a relatively small medical technology company (market cap around $62 million, only 21 employees) focused specifically on developing ECG solutions for detecting and monitoring heart conditions. This means news directly related to their technology and collaborations, like the one announced today, is particularly important and can have a significant impact on the stock price, as we saw today. It's a specialized niche, so developments in that area are crucial.


Disclaimer: This analysis is based solely on the provided data and is for informational purposes only. It is not financial advice. Stock investing involves risk, and prices can go down as well as up. You should always conduct your own thorough research and consider consulting with a qualified financial advisor before making any investment decisions.

相关新闻

BusinessWire

HeartBeam and AccurKardia Announce Strategic Collaboration to Advance Cardiac Monitoring Innovation

Collaboration brings together two leaders in ambulatory ECG recording and analysis HeartBeam, Inc. (NASDAQ:BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized

查看更多
HeartBeam and AccurKardia Announce Strategic Collaboration to Advance Cardiac Monitoring Innovation

AI预测Beta

AI建议

看跌

更新于: 2025年4月28日 19:15

看跌中性看涨

57.4% 置信度

风险与交易

风险等级3/5
中风险
适合于
价值
交易指南

入场点

$1.98

止盈点

$2.15

止损点

$1.77

关键因素

当前价格较MA(20)低3.2%,位于$2.04,表明有下行趋势
DMI显示看跌趋势(ADX:18.1,+DI:25.7,-DI:36.0),表明需谨慎
当前价格非常接近支撑水平$1.99,表明有强烈的买入机会
交易量是平均值的2.3倍(2,392),表明有显著的买入兴趣
MACD -0.0103低于信号线0.0036,表明看跌交叉

保持更新

设置价格提醒,获取AI分析更新和实时市场新闻。